IMA compared with ELDN: revenue, margins and what each company keeps, and the suppliers and customers both name

IMAImageneBio, Inc.

Mkt capRevenueRevenue

ELDNEledon Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

IMAImageneBio, Inc.

ELDNEledon Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

IMA, solidELDN, dashed

Supply-chain overlap

Revenue flow

IMA: latest quarter is a loss; flow not drawable. ELDN: latest quarter not drawable.Method ›

IMAImageneBio, Inc.

4.15▲+2.47%· post 4.15

Mkt cap$46.5MRevenue$800,000Q4 FY25

ELDNEledon Pharmaceuticals, Inc.

2.78▼−8.55%· post 2.83

ClosedOct 30 '26

Mkt cap$225.1MRevenue—

Compare

ClosedOct 30 '26

IMAImageneBio, Inc.

ELDNEledon Pharmaceuticals, Inc.

4.15▲+2.47%post 4.15

Price

2.78▼−8.55%post 2.83

$46.5M

Mkt cap

$225.1M

Q4 FY25$800,000

Revenue

—

IMA4.15▲+2.47%vsELDN2.78▼−8.55%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IMA 3

—Hutchmedunlistedsupplier

—Wuxi Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

Shared 0

No shared counterparties.

Only ELDN 1

NCELNewcelXsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR